Christopher Chapron
4Patents
0h-index
23Co-inventors
34Inventor score
Filing activity: Jul 11, 2019 → Dec 19, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12252531B2 | Methods of screening for high-affinity, isoform-selective TGFβ1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11130803B2 | Isoform-selective TGFβ1 inhibitors and use thereof | Chemistry; Metallurgy | 0 | Active |
| US12338279B2 | Selective and potent inhibitory antibodies of myostatin activation | Chemistry; Metallurgy | 0 | Active |
| US12122823B2 | Isoform-selective TGFB1 inhibitors and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.